Sign in

CIK 0001628171 · Large accelerated filer

Revolution Medicines, Inc.

Sign in to watch
Ticker
RVMD
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
472029180
Phone
650-481-6801
Business address
700 SAGINAW DR, REDWOOD CITY, CA, 94063

Securities

  • RVMD Common Stock Nasdaq
  • RVMDW Warrant Nasdaq
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$85,328,124
in 21 filings, $85.3M under 10b5-1 plans

Net −$85,328,124. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. GOLDSMITH MARK A −$20.8M See Remarks sold 28% of stake
  2. Kelsey Stephen Michael −$19.8M See Remarks sold 26% of stake
  3. Kim Lorence H. −$15.0M Director sold 100% of stake
  4. Cislini Jeff −$12.7M SVP & General Counsel sold 54% of stake
  5. Anders Jack −$7.5M Chief Financial Officer sold 25% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-09-02 Anders Jack Chief Financial Officer Option exercise 10b5-1 +2,814 $2.68 $8K 116,128
2025-09-02 Anders Jack Chief Financial Officer Option exercise 10b5-1 +1,948 $4.73 $9K 118,076
2025-09-02 Anders Jack Chief Financial Officer Sale 10b5-1 −4,762 $40.02 $191K 113,314
2025-09-02 Anders Jack Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −2,814 0
2025-09-02 Anders Jack Chief Financial Officer Option exercise · Stock Option (Right to Buy) 10b5-1 −1,948 3,189
2025-06-30 GOLDSMITH MARK A See Remarks Option exercise +37,000 $0.54 $20K 465,720
2025-06-30 GOLDSMITH MARK A See Remarks Option exercise · Stock Option (Right to Buy) −37,000 168,503
2025-06-26 Horning Sandra Director Grant or award +3,142 96,574
2025-06-26 Horning Sandra Director Grant or award · Stock Option (Right to Buy) +11,574 11,574
2025-06-26 Patel Sushil Director Grant or award +3,142 23,090
2025-06-26 Patel Sushil Director Grant or award · Stock Option (Right to Buy) +11,574 11,574
2025-06-26 Kim Lorence H. Director Grant or award +3,142 73,090
2025-06-26 Kim Lorence H. Director Grant or award · Stock Option (Right to Buy) +11,574 11,574
2025-06-26 Borisy Alexis Director Grant or award +3,142 2,338,884
2025-06-26 Borisy Alexis Director Grant or award · Stock Option (Right to Buy) +11,574 11,574
2025-06-26 Borellini Flavia Director Grant or award +3,142 25,024
2025-06-26 Borellini Flavia Director Grant or award · Stock Option (Right to Buy) +11,574 11,574
2025-06-26 ANDERSON ELIZABETH M Director Grant or award +3,142 23,215
2025-06-26 ANDERSON ELIZABETH M Director Grant or award · Stock Option (Right to Buy) +11,574 11,574
2025-06-26 Clyburn Frank Director Grant or award +2,806 9,738

Page 17 of 18 · 352 trades